Patents Assigned to The University
  • Patent number: 11573181
    Abstract: A method of imaging described herein comprises (a) disposing ultrasound-switchable fluorophores within an environment; (b) exposing the environment to ultrasound to create a first activation region within the environment; (c) disposing the fluorophores within the first activation region to switch the fluorophores from an off state to an on state; (d) irradiating the environment to excite the fluorophores within the first activation region; (e) detecting photoluminescence from the excited fluorophores at a first optical spot on an exterior surface of the environment; (f) subsequently creating a second activation region within the environment; (g) switching fluorophores within the second activation region to an on state; (h) exciting the fluorophores in the on state within the second activation region; and (i) detecting photoluminescence from the excited fluorophores within the second activation region at a second optical spot on the exterior surface, wherein the first and second optical spots are optically res
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: February 7, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Baohong Yuan, Tingfeng Yao
  • Patent number: 11571443
    Abstract: The disclosure provides products and methods of treating diseases and disorders involving microbial pathogens, such as intestinal microbial pathogens, e.g., Pseudomonas aeruginosa, by administering an effective amount of a phosphorylated polyethylene glycol compound of defined structural organization. Those diseases and disorders characterized by an epithelium attacked by a microbial pathogen are contemplated, including gastrointestinal infections and inflammation, e.g., treatment of intestinal or esophageal anastomosis or treatment or suppression of anastomotic leakage.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: February 7, 2023
    Assignee: The University of Chicago
    Inventors: John C. Alverdy, Matthew Tirrell, Olga Y. Zaborina, Jun Mao, Wei Chen
  • Patent number: 11574747
    Abstract: The methods and compositions described herein address the need in the art by providing compositions and methods for a therapy with an antibody that is specifically targeted to and/or retained intra- or peri-tumorally, limiting systemic exposure and reducing side-effects. Accordingly, aspects of the disclosure relate to a composition comprising an immunotherapeutic antibody operatively linked to an extracellular matrix (ECM)-affinity peptide. An ECM-affinity peptide is one that has affinity for an extracellular matrix protein.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: February 7, 2023
    Assignee: The University of Chicago
    Inventors: Jeffrey A. Hubbell, Jun Ishihara, Ako Ishihara, Kazuto Fukunaga, Melody Swartz
  • Patent number: 11572780
    Abstract: Impedance is used to determine the performance of paraffin inhibitors in oil containing paraffin. The method and system can use a specially designed impedance cell having a cell constant of less than 1 cm?1. Further, the method can include obtaining at least impedance measurements above the wax appearance temperature (WAT) for an oil sample treated with a paraffin inhibitor and an oil sample not treated, and impedance measurements below the WAT for the treated oil sample and the untreated oil sample. Thereafter, the impedance measurements are correlated to determine paraffin inhibitor performance.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: February 7, 2023
    Assignee: The University of Tulsa
    Inventors: Marc Tappert, Dale Teeters
  • Patent number: 11571978
    Abstract: A charging cable apparatus having a connector, an electrically-conductive cable extending from the connector, the cable configured to be connectable to a charging station for receiving a charging current from the charging station, and having a heat pipe with a phase change section having a wicking structure, the wicking structure having a working fluid therein during operation for receiving heat generated during current flow within the cable. The charging cable apparatus may further have an external condensing surface in fluid communication with the phase change section of the heat pipe for accelerating condensation of evaporated working fluid. The charging cable apparatus may be connected to a charging station for charging an electric battery such as a battery of an electric vehicle.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: February 7, 2023
    Assignees: The Board of Regents of the University of Oklahoma, The Board of the Trustees of the Leland Stanford Junior University, The University of Connecticut
    Inventors: Hamidreza Shabgard, Amir Faghri, Kenneth Goodson, Mehdi Asheghi
  • Patent number: 11572355
    Abstract: The present disclosure provide synthetic methods for the synthesis of N-substituted vinylidene and alkene compounds in addition to compounds formed from such methods.
    Type: Grant
    Filed: May 17, 2021
    Date of Patent: February 7, 2023
    Assignee: The Board of Trustees of The University of Alabama
    Inventors: Jason Edward Bara, Kathryn Elizabeth O'Harra
  • Patent number: 11572629
    Abstract: The present invention provides methods for producing hydrogen using a mediator that is capable of reversibly donating and accepting four or more electrons. A method of the invention comprises the steps of reducing a mediator by four or more electrons to yield a reduced mediator, and oxidising a reduced mediator to yield a mediator, and reducing protons to yield hydrogen.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: February 7, 2023
    Assignee: The University Court of the University of Glasgow
    Inventors: Leroy Cronin, Mark Symes, Jia-Jia Chen
  • Patent number: 11572569
    Abstract: The present disclosure provides a transgenic plant comprising one or more nucleotide sequences encoding polypeptides selected from photosystem II subunit S (PsbS), zeaxanthin epoxidase (ZEP), and violaxanthin de-epoxidase (VDE), operably linked to at least one expression control sequence. Expression vectors for making transgenic plants, and methods for increasing biomass production and/or carbon fixation and/or growth in a plant comprising increasing expression of at least one of PsbS, ZEP and VDE polypeptides are also provided.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: February 7, 2023
    Assignees: The Board of Trustees of The University Of Illinois, The Regents of the University of California
    Inventors: Stephen P. Long, Johannes Kromdijk, Katarzyna Glowacka, Krishna K. Niyogi, Laurie Leonelli, Stephane T. Gabilly
  • Publication number: 20230034192
    Abstract: Systems and methods for simulating subterranean regions having multi-scale, complex fracture geometries. Non-intrusive embedded discrete fracture modeling formulations are applied in conjunction with commercial or in-house simulators to efficiently and accurately model subsurface characteristics including temperature profiles in regions having complex hydraulic fractures, complex natural fractures, or a combination of both.
    Type: Application
    Filed: July 14, 2021
    Publication date: February 2, 2023
    Applicants: Sim Tech LLC, Board of Regents, The University of Texas System
    Inventors: Kamy Sepehrnoori, He Sun, Wei Yu, Jijun Miao
  • Publication number: 20230033395
    Abstract: Disclosed is a lithium ion battery comprising a lithium anode, a tellurium cathode and a gel polymer electrolyte. The gel polymer electrolyte may comprise a polymer matrix and a lithium compatible salt.
    Type: Application
    Filed: July 23, 2021
    Publication date: February 2, 2023
    Applicant: The University of British Columbia
    Inventors: Yue Zhang, Dan Oliric Manaig, Don J. Freschi, Jian Liu
  • Publication number: 20230036839
    Abstract: Nanoparticles comprising micheliolide (MCL) or derivatives thereof, and optionally additional therapeutic agents, such as chemotherapeutic agents, are described. Also described are methods of treating diseases, such as cancer, comprising the use of combinations of MCL or a derivative thereof with X-ray irradiation and/or other therapeutic agents, such as immune checkpoint inhibitors. The use of the combinations can provide synergistic anticancer therapeutic efficacy, for example, as the MCL or derivative thereof can both sensitize cancer cells to therapy and target resistant cancer stem cells (CSCs) for selective cell death.
    Type: Application
    Filed: June 30, 2022
    Publication date: February 2, 2023
    Applicant: The University of Chicago
    Inventors: Wenbin Lin, Christina Chan, Wenbo Han
  • Patent number: 11564932
    Abstract: Embodiments of the invention are directed to the treatment of subjects with prostate cancer, in particular those with castration resistant prostate cancer, with glucocorticoid receptor antagonists. The prostate cancer may be one that has become resistant to androgen deprivation therapy, for example, by increase in glucocorticoid receptor expression and/or activity.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: January 31, 2023
    Assignee: The University of Chicago
    Inventors: Russell Z. Szmulewitz, Suzanne D. Conzen
  • Patent number: 11566077
    Abstract: Provided herein are compositions and methods for detecting and/or targeting dysfunctional tumor antigen-specific CD8+ T cells in the tumor microenvironment for diagnostic, therapeutic and/or research applications. In particular, dysfunctional tumor antigen-specific CD8+ T cells are detected and/or targeted via their expression of cell surface receptors described herein, such as 4-1BB, LAG-3, or additional markers that correlate with 4-1BB and LAG-3 expression, such as markers differentially expressed on the surface of the T cells.
    Type: Grant
    Filed: January 17, 2018
    Date of Patent: January 31, 2023
    Assignee: The University of Chicago
    Inventors: Thomas Gajewski, Jason Williams, Brendan Horton
  • Patent number: 11564623
    Abstract: Systems and methods for monitoring food intake include an air pressure sensor for detecting ear canal deformation, according to some implementations. For example, the air pressure sensor detects a change in air pressure in the ear canal resulting from mandible movement. Other implementations include systems and methods for monitoring food intake that include a temporalis muscle activity sensor for detecting temporalis muscle activity, wherein at least a portion of the temporalis muscle activity sensor is coupled adjacent a temple portion of eyeglasses and disposed between the temple tip and the frame end piece. The temporalis muscle activity sensor may include an accelerometer, for example, for detecting movement of the temple portion due to mandibular movement from chewing.
    Type: Grant
    Filed: May 17, 2021
    Date of Patent: January 31, 2023
    Assignee: The Board of Trustees of The University of Alabama
    Inventors: Edward Sazonov, Muhammad Farooq
  • Patent number: 11564873
    Abstract: The present invention relates to improved complexes of amorphous calcium phosphate and/or amorphous calcium fluoride phosphate stabilised by phosphopeptides/phosphoproteins by addition of stannous ions. These complexes have anticariogenic properties useful to protect tooth structures as they remineralize (repair) early stages of dental caries and have other dental/medical applications (including anti-calculus, anti-erosion/corrosion and anti-dentinal hypersensitivity). Methods of making the complexes of the invention and of treatment or prevention of various dental conditions including dental caries, dental calculus, dental erosion/corrosion and dental hypersensitivity are also provided.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: January 31, 2023
    Assignee: The University of Melbourne
    Inventor: Eric Charles Reynolds
  • Patent number: 11566213
    Abstract: A microfabricated device having at least one gas-entrapping feature formed therein in a configuration that entraps air bubbles upon wetting the feature with a solvent or solution is described. The device includes a sacrificial residue in contact with the gas-entrapping feature, the dissolution of which guides the wetting of the gas-entrapping feature.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: January 31, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Nancy L. Allbritton, Yuli Wang, Christopher Sims
  • Patent number: 11566050
    Abstract: The present invention is directed to methods and compositions for norovirus therapeutics, such as vaccines, and diagnostics.
    Type: Grant
    Filed: October 18, 2018
    Date of Patent: January 31, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Lisa Chon Lindesmith, Ralph Steven Baric, Kari Moore Debbink, Eric Francis Donaldson
  • Publication number: 20230028660
    Abstract: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
    Type: Application
    Filed: August 30, 2022
    Publication date: January 26, 2023
    Applicant: The University of Sydney
    Inventors: Michael KASSIOU, William JORGENSEN, Lenka MUNOZ
  • Publication number: 20230024822
    Abstract: Aspects of self-powered weigh-in-motion systems and methods that utilize piezoelectric components for sensing load as well as powering data acquisition and analysis components. In one example, the weigh-in-motion system includes a number of piezoelectric stacks, each stack including a number of piezoelectric elements. Each stack includes one or more top or upper piezoelectric element that provides vehicle sensing data. Each stack also includes a set of piezoelectric elements used for energy harvesting. The sensing piezoelectric elements are connected to a data input of a microcontroller for vehicle classification, while the energy harvesting piezoelectric elements are connected to a power input of the microcontroller.
    Type: Application
    Filed: July 7, 2022
    Publication date: January 26, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventors: Sara Ahmed, Mohamadreza Khalili, Athanassios Thomas Pagagiannakis, Gopal Vishwakarma, Samer Dessouky
  • Publication number: 20230026843
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Application
    Filed: September 4, 2022
    Publication date: January 26, 2023
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Qiang CHENG, Tuo WEI, Daniel J. SIEGWART